Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption.

Giménez-Esparza C, Portillo-Requena C, Colomina-Climent F, Allegue-Gallego JM, Galindo-Martínez M, Mollà-Jiménez C, Antón-Pascual JL, Mármol-Peis E, Dólera-Moreno C, Rodríguez-Serra M, Martín-Ruíz JL, Fernández-Arroyo PJ, Blasco-Císcar EM, Cánovas-Robles J, González-Hernández E, Sánchez-Morán F, Solera-Suárez M, Torres-Tortajada J, Palazón-Bru A, Gil-Guillen VF.

BMJ Open. 2019 Dec 3;9(12):e030139. doi: 10.1136/bmjopen-2019-030139.

2.

A critical appraisal of the clinical applicability and risk of bias of the predictive models for mortality and recurrence in patients with oropharyngeal cancer: Systematic review.

Palazón-Bru A, Mares-García E, López-Bru D, Mares-Arambul E, Folgado-de la Rosa DM, Carbonell-Torregrosa MLÁ, Gil-Guillén VF.

Head Neck. 2019 Nov 24. doi: 10.1002/hed.26025. [Epub ahead of print] Review.

PMID:
31762119
3.

Detection of frailty in older patients using a mobile app: cross-sectional observational study in primary care.

Aznar-Tortonda V, Palazón-Bru A, Folgado-de la Rosa DM, Espínola-Morel V, Pérez-Pérez BF, León-Ruiz AB, Gil-Guillén VF.

Br J Gen Pract. 2019 Nov 4. pii: bjgp19X706577. doi: 10.3399/bjgp19X706577. [Epub ahead of print]

PMID:
31685541
4.

Predictive validity of the risk SCORE model in a Mediterranean population with dyslipidemia.

Bertomeu-González V, Soriano Maldonado C, Bleda-Cano J, Carrascosa-Gonzalvo S, Navarro-Perez J, López-Pineda A, Carratalá-Munuera C, Gil Guillén VF, Quesada JA, Brotons C, Orozco-Beltrán D.

Atherosclerosis. 2019 Nov;290:80-86. doi: 10.1016/j.atherosclerosis.2019.09.007. Epub 2019 Sep 23.

PMID:
31593904
5.

A systematic review of predictive models for recurrence and mortality in patients with tongue cancer.

Palazón-Bru A, Mares-García E, López-Bru D, Mares-Arambul E, Gil-Guillén VF, Carbonell-Torregrosa MÁ.

Eur J Cancer Care (Engl). 2019 Nov;28(6):e13157. doi: 10.1111/ecc.13157. Epub 2019 Aug 23. Review.

PMID:
31441567
6.

Factors associated with moderate neonatal hyperthyrotropinemia.

Cortés-Castell E, Juste M, Palazón-Bru A, Goicoechea M, Gil-Guillén VF, Rizo-Baeza MM.

PLoS One. 2019 Jul 18;14(7):e0220040. doi: 10.1371/journal.pone.0220040. eCollection 2019.

7.

Machine learning to predict cardiovascular risk.

Quesada JA, Lopez-Pineda A, Gil-Guillén VF, Durazo-Arvizu R, Orozco-Beltrán D, López-Domenech A, Carratalá-Munuera C.

Int J Clin Pract. 2019 Oct;73(10):e13389. doi: 10.1111/ijcp.13389. Epub 2019 Aug 4.

PMID:
31264310
8.

A systematic review of non-pharmacological interventions to improve therapeutic adherence in tuberculosis.

Riquelme-Miralles D, Palazón-Bru A, Sepehri A, Gil-Guillén VF.

Heart Lung. 2019 Sep - Oct;48(5):452-461. doi: 10.1016/j.hrtlng.2019.05.001. Epub 2019 May 11. Review.

PMID:
31084923
9.

A cardiovascular risk score for hypertensive patients previously admitted to hospital.

Martínez-Díaz AM, Palazón-Bru A, Folgado-de la Rosa DM, Ramírez-Prado D, Llópez-Espinós P, Beneyto-Ripoll C, Gil-Guillén VF.

Eur J Cardiovasc Nurs. 2019 Aug;18(6):492-500. doi: 10.1177/1474515119845791. Epub 2019 Apr 28.

PMID:
31032627
10.

Clinical inertia in hypertension: a new holistic and practical concept within the cardiovascular continuum and clinical care process.

Pallarés-Carratalá V, Bonig-Trigueros I, Palazón-Bru A, Esteban-Giner MJ, Gil-Guillén VF, Giner-Galvañ V.

Blood Press. 2019 Aug;28(4):217-228. doi: 10.1080/08037051.2019.1608134. Epub 2019 Apr 26.

PMID:
31023106
11.

Plantar pressure improvement in moderate hallux valgus with modified chevron osteotomy: Clinical and radiographic outcomes.

Verdu-Roman C, Sanz-Reig J, Martinez-Gimenez E, Carratala-Munuera C, Lopez-Pineda A, Quesada JA, Gil-Guillen VF, Orozco-Beltran D.

Foot Ankle Surg. 2019 Feb 27. pii: S1268-7731(18)30426-0. doi: 10.1016/j.fas.2019.02.006. [Epub ahead of print]

PMID:
30871917
12.

The FIFA 11 programme reduces the costs associated with ankle and hamstring injuries in amateur Spanish football players: A retrospective cohort study.

Nouni-Garcia R, Asensio-Garcia MR, Orozco-Beltran D, Lopez-Pineda A, Gil-Guillen VF, Quesada JA, Bernabeu Casas RC, Carratala-Munuera C.

Eur J Sport Sci. 2019 Sep;19(8):1150-1156. doi: 10.1080/17461391.2019.1577495. Epub 2019 Mar 4.

PMID:
30829121
13.

Maternal periodontitis and preterm birth: Systematic review and meta-analysis.

Manrique-Corredor EJ, Orozco-Beltran D, Lopez-Pineda A, Quesada JA, Gil-Guillen VF, Carratala-Munuera C.

Community Dent Oral Epidemiol. 2019 Jun;47(3):243-251. doi: 10.1111/cdoe.12450. Epub 2019 Feb 27.

PMID:
30812054
14.

Worldwide scientific production in obstetrics: a bibliometric analysis.

Palacios-Marqués AM, Carratala-Munuera C, Martínez-Escoriza JC, Gil-Guillen VF, Lopez-Pineda A, Quesada JA, Orozco-Beltrán D.

Ir J Med Sci. 2019 Aug;188(3):913-919. doi: 10.1007/s11845-018-1954-3. Epub 2019 Jan 9.

PMID:
30627959
15.

Association between the Foot Posture Index and running related injuries: A case-control study.

Pérez-Morcillo A, Gómez-Bernal A, Gil-Guillen VF, Alfaro-Santafé J, Alfaro-Santafé JV, Quesada JA, Lopez-Pineda A, Orozco-Beltran D, Carratalá-Munuera C.

Clin Biomech (Bristol, Avon). 2019 Jan;61:217-221. doi: 10.1016/j.clinbiomech.2018.12.019. Epub 2018 Dec 22.

PMID:
30599386
16.

A Reliability Generalization Meta-Analysis of the Victorian Institute of Sport Assessment Scale for Achilles Tendinopathy (VISA-A).

Palazón-Bru A, Tomás-Rodríguez MI, Mares-García E, Gil-Guillén VF.

Foot Ankle Int. 2019 Apr;40(4):430-438. doi: 10.1177/1071100718816953. Epub 2018 Dec 20.

PMID:
30569746
17.

A scoring system to predict recurrence in breast cancer patients.

Paredes-Aracil E, Palazón-Bru A, Folgado-de la Rosa DM, Ots-Gutiérrez JR, Llorca-Ferrándiz C, Alonso-Hernández S, Coloma-Lidón JV, Gil-Guillén VF.

Surg Oncol. 2018 Dec;27(4):681-687. doi: 10.1016/j.suronc.2018.09.005. Epub 2018 Sep 18.

PMID:
30449493
18.

Comparison Between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol to Estimate Cardiovascular Risk Using a Multivariate Model.

Palazón-Bru A, Carbayo-Herencia JA, Simarro-Rueda M, Artigao-Ródenas LM, Divisón-Garrote JA, Molina-Escribano F, Ponce-García I, Gil-Guillén VF; GEVA (Group of Vascular Diseases From Albacete).

J Cardiovasc Nurs. 2018 Nov/Dec;33(6):E17-E23. doi: 10.1097/JCN.0000000000000534.

PMID:
30273261
19.

Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.

Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, de la Torre MP, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group.

PLoS One. 2018 Sep 27;13(9):e0205047. doi: 10.1371/journal.pone.0205047. eCollection 2018.

20.

A scoring system to predict recurrence in patients with differentiated thyroid cancer.

López-Bru D, Palazón-Bru A, Folgado-de la Rosa DM, Gil-Guillén VF.

Clin Otolaryngol. 2019 Jan;44(1):26-31. doi: 10.1111/coa.13227. Epub 2018 Oct 9.

PMID:
30220101
21.

A scoring system to detect fixed airflow limitation in smokers from simple easy-to-use parameters.

Román-Conejos E, Palazón-Bru A, Folgado-de la Rosa DM, Sánchez-Molla M, Rizo-Baeza MM, Gil-Guillén VF, Cortés-Castell E.

Sci Rep. 2018 Sep 6;8(1):13329. doi: 10.1038/s41598-018-31198-8.

22.

A one-year risk score to predict all-cause mortality in hypertensive inpatients.

Martínez-Díaz AM, Palazón-Bru A, Folgado-de la Rosa DM, Ramírez-Prado D, Navarro-Juan M, Pérez-Ramírez N, Gil-Guillén VF.

Eur J Intern Med. 2019 Jan;59:77-83. doi: 10.1016/j.ejim.2018.07.010. Epub 2018 Jul 13.

PMID:
30007839
23.

Adherence to European Clinical Practice Guidelines for Secondary Prevention of Cardiovascular Disease: A Cohort Study.

Pepió Vilaubí JM, Orozco-Beltrán D, Gonçalves AQ, Rodriguez Cumplido D, Aguilar Martin C, Lopez-Pineda A, Gil-Guillen VF, Quesada JA, Carratala-Munuera C.

Int J Environ Res Public Health. 2018 Jun 11;15(6). pii: E1233. doi: 10.3390/ijerph15061233.

24.

Response to the Comment on: Factors Associated with Increased Pain in Primary Dysmenorrhea: Analysis Using a Multivariate Ordered Logistic Regression Model.

Palazón-Bru A, Tomás-Rodríguez MI, Toledo-Marhuenda JV, Gil-Guillén VF.

J Pediatr Adolesc Gynecol. 2018 Aug;31(4):433. doi: 10.1016/j.jpag.2018.03.009. No abstract available.

PMID:
29891051
25.

A scoring system to predict 5-year mortality in patients diagnosed with laryngeal glottic cancer.

Jover-Esplá AG, Palazón-Bru A, Folgado-de la Rosa DM, de Juan-Herrero J, Gil-Guillén VF.

Eur J Cancer Care (Engl). 2018 Jul;27(4):e12860. doi: 10.1111/ecc.12860. Epub 2018 Jun 5.

PMID:
29870075
26.

Validation of the electronic prescription as a method for measuring treatment adherence in hypertension.

Márquez-Contreras E, López García-Ramos L, Martell-Claros N, Gil-Guillen VF, Márquez-Rivero S, Pérez-López E, Garrido-Lopez MA, Farauste C, López-Pineda A, Casado-Martinez JJ, Orozco-Beltran D, Quesada JA, Carratalá-Munuera C.

Patient Educ Couns. 2018 Sep;101(9):1654-1660. doi: 10.1016/j.pec.2018.04.009. Epub 2018 Apr 23.

PMID:
29731180
27.

A predictive model for recurrence in patients with glottic cancer implemented in a mobile application for Android.

Jover-Esplá AG, Palazón-Bru A, Folgado-de la Rosa DM, Severá-Ferrándiz G, Sancho-Mestre M, de Juan-Herrero J, Gil-Guillén VF.

Oral Oncol. 2018 May;80:82-88. doi: 10.1016/j.oraloncology.2018.03.021. Epub 2018 Apr 4.

PMID:
29706192
28.

Therapeutic inertia in anti-platelet therapy in patients with a cardiovascular event attended in an emergency department.

García-Macías JA, Palazón-Bru A, Carbonell-Torregrosa MÁ, Navarro-Juan M, Gil-Guillén VF.

Curr Med Res Opin. 2019 Mar;35(3):455-459. doi: 10.1080/03007995.2018.1469480. Epub 2018 May 21.

PMID:
29690773
29.

Association analysis between hyperuricemia and long term mortality after acute coronary syndrome in three subgroups of patients.

Lopez-Pineda A, Cordero A, Carratala-Munuera C, Orozco-Beltran D, Quesada JA, Bertomeu-Gonzalez V, Gil-Guillen VF, Bertomeu-Martinez V.

Data Brief. 2018 Feb 5;17:885-889. doi: 10.1016/j.dib.2018.01.101. eCollection 2018 Apr.

30.

Inappropriate Use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases.

Pérez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, López-Pineda A, Orozco-Beltrán D.

Int J Environ Res Public Health. 2018 Feb 10;15(2). pii: E310. doi: 10.3390/ijerph15020310. Review.

31.

Hyperuricemia as a prognostic factor after acute coronary syndrome.

Lopez-Pineda A, Cordero A, Carratala-Munuera C, Orozco-Beltran D, Quesada JA, Bertomeu-Gonzalez V, Gil-Guillen VF, Bertomeu-Martinez V.

Atherosclerosis. 2018 Feb;269:229-235. doi: 10.1016/j.atherosclerosis.2018.01.017. Epub 2018 Jan 17.

PMID:
29407598
32.

Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort.

Carbayo Herencia JA, Simarro Rueda M, Palazón Bru A, Molina Escribano F, Ponce García I, Artigao Ródenas LM, Caldevilla Bernardo D, Divisón Garrote JA, Gil Guillén VF; Todos en nombre del Grupo de Enfermedades Vasculares de Albacete (GEVA).

Clin Investig Arterioscler. 2018 Mar - Apr;30(2):64-71. doi: 10.1016/j.arteri.2017.10.003. Epub 2018 Feb 1. English, Spanish.

PMID:
29395492
33.

A brief comment about predictive models for mortality in intensive care units.

Palazón-Bru A, Colomina-Climent F, Dólera-Moreno C, Folgado-de la Rosa DM, Gil-Guillén VF.

Acta Anaesthesiol Scand. 2018 Mar;62(3):404. doi: 10.1111/aas.13076. Epub 2018 Jan 24. No abstract available.

PMID:
29363094
34.

Trends in Premature Mortality Due to Heart Failure by Autonomous Community in Spain: 1999 to 2013.

Gómez-Martínez L, Orozco-Beltrán D, Quesada JA, Bertomeu-González V, Gil-Guillén VF, López-Pineda A, Carratalá-Munuera C.

Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):531-537. doi: 10.1016/j.rec.2017.09.026. Epub 2018 Jan 10. English, Spanish.

PMID:
29331563
35.

Screening Tool to Determine Risk of Having Muscle Dysmorphia Symptoms in Men Who Engage in Weight Training at a Gym.

Palazón-Bru A, Rizo-Baeza MM, Martínez-Segura A, Folgado-de la Rosa DM, Gil-Guillén VF, Cortés-Castell E.

Clin J Sport Med. 2018 Mar;28(2):168-173. doi: 10.1097/JSM.0000000000000422.

PMID:
29271781
36.

Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.

Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, Pascual de la Torre M, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group.

PLoS One. 2017 Oct 18;12(10):e0186196. doi: 10.1371/journal.pone.0186196. eCollection 2017. Erratum in: PLoS One. 2018 Sep 27;13(9):e0205047.

37.

External validation of cut-off points for foveal thickness taking into account the intraretinal fluid using optical coherence tomography to diagnose diabetic macular oedema.

Hernández-Martínez C, Palazón-Bru A, Azrak C, Navarro-Navarro A, Baeza-Díaz MV, Martínez-Toldos JJ, Gil-Guillén VF.

PeerJ. 2017 Oct 12;5:e3922. doi: 10.7717/peerj.3922. eCollection 2017.

38.

Influence of Written Informed Consent for Methylphenidate on Medicine Persistence Rates in Children with Attention-Deficit Hyperactivity Disorder.

Naenen-Hernani K, Palazón-Bru A, Colomina-Climent F, Gil-Guillén VF; GAIPNA (Alicante Research Group in Child and Adolescent Psychiatry).

J Dev Behav Pediatr. 2017 Oct;38(8):603-610. doi: 10.1097/DBP.0000000000000495.

PMID:
28816913
39.

Burnout syndrome in nurses working in palliative care units: An analysis of associated factors.

Rizo-Baeza M, Mendiola-Infante SV, Sepehri A, Palazón-Bru A, Gil-Guillén VF, Cortés-Castell E.

J Nurs Manag. 2018 Jan;26(1):19-25. doi: 10.1111/jonm.12506. Epub 2017 Jul 11.

PMID:
28695723
40.

Construction, internal validation and implementation in a mobile application of a scoring system to predict nonadherence to proton pump inhibitors.

Mares-García E, Palazón-Bru A, Folgado-de la Rosa DM, Pereira-Expósito A, Martínez-Martín Á, Cortés-Castell E, Gil-Guillén VF.

PeerJ. 2017 Jun 30;5:e3455. doi: 10.7717/peerj.3455. eCollection 2017.

41.

Multivariate Ordered Logistic Regression Models: Dealing with the Model-Building Strategy.

Palazón-Bru A, Tomás-Rodríguez MI, López-Cascales MT, Folgado-de la Rosa DM, Gil-Guillén VF.

J Pediatr Adolesc Gynecol. 2017 Dec;30(6):664. doi: 10.1016/j.jpag.2017.06.006. Epub 2017 Jun 27. No abstract available.

PMID:
28663155
42.

Clinical benefit of the FIFA 11 programme for the prevention of hamstring and lateral ankle ligament injuries among amateur soccer players.

Nouni-Garcia R, Carratala-Munuera C, Orozco-Beltran D, Lopez-Pineda A, Asensio-Garcia MR, Gil-Guillen VF.

Inj Prev. 2018 Apr;24(2):149-154. doi: 10.1136/injuryprev-2016-042267. Epub 2017 Jun 22.

PMID:
28642247
43.

Relationship between the rs1414334 C/G polymorphism in the HTR2C gene and smoking in patients treated with atypical antipsychotics.

Rico-Gomis JM, Palazón-Bru A, Triano-García I, Mahecha-García LF, García-Monsalve A, Navarro-Ruiz A, Villagordo-Peñalver B, Martínez-Hortelano A, Gil-Guillén VF.

Adicciones. 2018 Apr 15;30(2):123-129. doi: 10.20882/adicciones.876. English, Spanish.

44.

Sample size calculation to externally validate scoring systems based on logistic regression models.

Palazón-Bru A, Folgado-de la Rosa DM, Cortés-Castell E, López-Cascales MT, Gil-Guillén VF.

PLoS One. 2017 May 1;12(5):e0176726. doi: 10.1371/journal.pone.0176726. eCollection 2017.

45.

Mortality after out-of-hospital cardiac arrest in a Spanish Region.

Requena-Morales R, Palazón-Bru A, Rizo-Baeza MM, Adsuar-Quesada JM, Gil-Guillén VF, Cortés-Castell E.

PLoS One. 2017 Apr 13;12(4):e0175818. doi: 10.1371/journal.pone.0175818. eCollection 2017.

46.

A scoring system to predict breast cancer mortality at 5 and 10 years.

Paredes-Aracil E, Palazón-Bru A, Folgado-de la Rosa DM, Ots-Gutiérrez JR, Compañ-Rosique AF, Gil-Guillén VF.

Sci Rep. 2017 Mar 24;7(1):415. doi: 10.1038/s41598-017-00536-7.

47.

Non-guideline-recommended prescribing of proton pump inhibitors in the general population.

Mares-García E, Palazón-Bru A, Martínez-Martín Á, Folgado-de la Rosa DM, Pereira-Expósito A, Gil-Guillén VF.

Curr Med Res Opin. 2017 Oct;33(10):1725-1729. doi: 10.1080/03007995.2017.1308921. Epub 2017 Apr 19.

PMID:
28318318
48.

Impact of prematurity and immigration on neonatal screening for sickle cell disease.

Cortés-Castell E, Palazón-Bru A, Pla C, Goicoechea M, Rizo-Baeza MM, Juste M, Gil-Guillén VF.

PLoS One. 2017 Feb 7;12(2):e0171604. doi: 10.1371/journal.pone.0171604. eCollection 2017.

49.

An update to the internal validation of the new mortality risk score for patients admitted to the intensive care unit.

Palazón-Bru A, Dólera-Moreno C, Folgado-de la Rosa DM, Colomina-Climent F, Gil-Guillén VF.

Int J Clin Pract. 2016 Nov;70(11):961-962. doi: 10.1111/ijcp.12897. No abstract available.

PMID:
27870260
50.

Trends in Mortality From Diabetes Mellitus in Spain: 1998-2013.

Orozco-Beltrán D, Sánchez E, Garrido A, Quesada JA, Carratalá-Munuera MC, Gil-Guillén VF.

Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):433-443. doi: 10.1016/j.rec.2016.09.022. Epub 2016 Nov 5. English, Spanish.

PMID:
27825716

Supplemental Content

Loading ...
Support Center